Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

13/02/2024 06:00

Feb 13 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2023        Dec 31, 2022       Mar 31, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
                                    (-100.0 pct)                     
  Operating     loss 949 mln          loss 1.03         loss 1.31    
  Recurring     loss 971 mln          loss 1.04         loss 1.32    
  Net           loss 972 mln          loss 1.04         loss 1.32    
  EPS          loss 142.09 yen     loss 190.18 yen   loss 207.71 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T